Technology Transition Clause Samples

Technology Transition. Describe how the technology will be transitioned during and after the termination of the CRADA. The recommended result could be one or more of several examples: 7.6.1. A commercially developed product by the collaborator. 7.6.2. Software modules developed by NGA that would be transitioned to the firm for incorporation into their commercial software. 7.6.3. Development of a capability that would then require additional development to go into a commercial product. 7.6.4. Additional technology transfer and transition venues identified by government and industry.
View SourceView Similar (2)
Technology Transition. The Institute’s business plan and strategy to effect technology transition are critical to its long-term success, financial self-sufficiency, and economic impact. The technology transition strategy will affect the Institute management plan, technical focus areas, intellectual property and data management, and personnel. The Institute’s technology transition activities shall exercise fully its "industrial commons" and needs to be integral in the selection process for the Institute’s technical projects. There are several metals manufacturing technologies that the DoD has interest in scaling up from MRL 4 to MRL 7, and into production (MRL 8-9). These include, but are not limited to, the manufacturing of low-cost and high performing metal components and assemblies for lightweight ground, aerospace, and maritime systems; applications utilizing advanced alloys (e.g., titanium-, aluminum- and magnesium-based alloys and processing) and novel materials architectures (e.g., metallic foams, cellular structures, etc.) that reduce system weight; and materials for lightweight high-efficiency engines. The DoD also envisions that other government agencies will have similar manufacturing problems of interest for the LM3I Institute. These manufacturing challenges present practical objectives that can lead to new products for market expansion. They also allow engineers and researchers to address the core technology challenges associated with lightweight design in an integrated manner, using processes including ICME and its associated tools. As an initial example, four core metals manufacturing technology areas of interest for the LM3I Institute are: (1) applications of new/novel metals and alloys; (2) primary metal manufacturing processes; (3) secondary manufacturing processes; and (4) development of products exploiting lightweight and modern metals. It is recognized that a critical component of transition includes education and workforce development. Further, this list is not all-inclusive, and another categorization of the core technologies may offer superior utility.
View Source
Technology Transition. For a period not to exceed sixty (60) days following the Closing Date, the Seller will provide, at no additional charge, (i) reasonable technical assistance to Buyer with regards to the transfer of all IP related Purchased Assets together with (ii) reasonable training on the operation of and how to support the operation of all of the URL portals listed on Exhibit “A”.
View Source
Technology Transition. Seller shall fulfill its obligation with regard to the transition of technology as set forth in Section 5.4.
View Source
Technology Transition. If, on or before the date of the scheduled Closing, Seller and Purchaser shall not have completed all of the information and technology transfer and migration tasks contemplated by Sections 5.6(b) and 5.6(d), then the Closing shall be delayed until the first Business Day following the date on which the last of the transfer and migration activities described in Sections 5.6(b) and 5.6(d) shall have been completed; provided, however, that the Closing Date shall not be delayed pursuant to this Section 2.1(d) beyond June 28, 2013.
View Source

Related to Technology Transition

  • Technology Transfer Subject to the terms of the Development Supply Agreement, as soon as reasonably practicable, but in no event later than the fifth (5th) anniversary of the Effective Date, Alnylam shall initiate a technology transfer to MedCo, or to its Third Party manufacturer(s) of Licensed Product, selected by MedCo and reasonably acceptable to Alnylam, of Alnylam Know-How that is reasonably necessary or useful for the Manufacture of the Licensed Product, and shall make available its personnel on a reasonable basis to consult with MedCo or such Third Party manufacturer(s) with respect thereto, all at MedCo’s expense, including the Costs reasonably incurred by Alnylam in connection with such technology transfer activities. MedCo shall reimburse Alnylam such Costs incurred with respect to such Manufacturing technology transfer within [***] days after receipt of an invoice therefor. Alnylam and its Affiliates shall keep complete and accurate records in sufficient detail to enable the payments payable hereunder to be determined. Alnylam shall not be required to perform technology transfer to more than one Third Party manufacturer for each stage of the Licensed Product supply chain (i.e., Bulk Drug Substance, Bulk Drug Product and Finished Product). Promptly after MedCo’s written request, Alnylam shall use Commercially Reasonable Efforts to assign to MedCo any manufacturing agreement between Alnylam and a Third Party that is solely related to the manufacture of Licensed Products. Such assignment shall be subject to the terms and conditions of such agreement, including any required consents of such Third Party and MedCo’s written agreement to assume all the obligations of Alnylam under such agreement to be undertaken after such assignment, but Alnylam shall remain solely responsible for its obligations under such agreement arising prior to such assignment. Except as provided in the immediately preceding sentence, MedCo shall be solely responsible for contracting with such Third Party manufacturer (and any other Third Party manufacture to whom Alnylam has initiated technology transfer as set forth in this Section 5.3) for the supply of such Licensed Product and Alnylam shall have no obligations under such agreement between MedCo and such Third Party manufacturer. Alnylam shall use Commercially Reasonable Efforts to obtain any such consent in a form reasonably acceptable to MedCo.

  • Manufacturing Technology Transfer Except as provided in Section 4.3(f)(iii)(1) and Section 6.10, with respect to any Collaboration Product (or LGC Reserved Product, if applicable) for which LGC (or its Affiliate) performed CMC Development or CMC Manufacturing, if (a) Cue does not elect for LGC to perform CMC Step 2, CMC Step 3, or CMC Step 4 (or with respect to LGC Reserved Products, upon completion of CMC Step 1), or (b) upon failure of the Parties to reach agreement with respect to a Clinical Supply Agreement or a Commercial Supply Agreement or (c) [***] under this Agreement and does not cure such breach within [***] days (provided, that if such breach is not reasonably capable of cure within such [***] day period, then such cure period shall be automatically extended for an additional [***] day period as long as LGC continues to use diligent efforts to cure such breach in accordance with a reasonable cure plan and if such breach is not reasonably capable of cure within such combined [***] day period, then Cue shall reasonably consider consenting to any extension of such cure period as long as LGC continues to use diligent efforts to cure such breach in accordance with a reasonable cure plan), as applicable, then, in each case upon the written request of Cue, LGC shall use Commercially Reasonable Efforts to make a technology transfer to an Approved CMO the Manufacturing processes (including materials and such other information) but solely as is necessary to enable the Manufacture of such Collaboration Product (including the Collaboration Compound therein) (or LGC Reserved Product, including the LGC Reserved Compound therein, if applicable) by such Approved CMO to comparable biochemical structure, quality and purity as that Manufactured by LGC or its Affiliate or CMO, provided that neither Cue, LGC or any Third Party shall perform such a technology transfer to any CMO [***] without LGC’s consent, not to be unreasonably withheld, conditioned or delayed if LGC has approved the CMO to manufacture Collaboration Products (or LGC Reserved Products, if applicable). LGC shall conduct such technology transfer as soon as reasonably practicable after receiving such written notice, using good faith efforts to support supply needed to achieve timelines in the Cue Territory Development Plan (or Cue’s development plan for LGC Reserved Products, if applicable) or Cue Territory Commercialization Plan, as applicable. LGC shall conduct the first technology transfer for each Collaboration Product (or LGC Reserved Products, if applicable) [***] (provided that [***]) for a period of up to [***] months from the date Cue or its designee has provided notice it is ready to receive the technology transfer, provided, that such [***] month period [***]. After the expiration of the initial such [***] month period for a Collaboration Product (or LGC Reserved Products, if applicable), if required to complete the technology transfer to enable the Manufacture of such Collaboration Product (including the Collaboration Compound therein) (or LGC Reserved Product, including the LGC Reserved Compound therein, if applicable) by such Approved CMO to comparable biochemical structure, quality and purity as that Manufactured by LGC, LGC shall continue to provide support to Cue for up to an additional [***] period for up to [***] hours at the FTE Rate and thereafter at [***]. Thereafter, LGC will also provide [***] for such Collaboration Product (or LGC Reserved Products, if applicable). Neither Cue nor its Affiliates or Cue Collaborators shall reverse engineer any materials provided hereunder by LGC. Notwithstanding anything in this Agreement to the contrary, LGC’s CMC information may only be shared with an Approved CMO.

  • Technology Research Analyst Job# 1810 General Characteristics

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK

  • Software Development Software designs, prototypes, and all documentation for the final designs developed under this agreement must be made fully transferable upon direction of NSF. NSF may make the software design, prototype, and documentation for the final design available to competitors for review during any anticipated re-competition of the project.